SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-21-013380
Filing Date
2021-07-14
Accepted
2021-07-14 16:27:15
Documents
1
Period of Report
2021-07-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4025
  Complete submission text file 0001567619-21-013380.txt   5621
Mailing Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080 415-798-8589
Tempest Therapeutics, Inc. (Issuer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 20005
Business Address
Maestas Nicholas (Reporting) CIK: 0001871423 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35890 | Film No.: 211090466